- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06832553
The Effect of Surgical Incision Drep Use in Endotracheal Tube Fixation
March 11, 2025 updated by: Barış Çelik, Hasan Kalyoncu University
The Effect of Surgical Incision Drep Use in Endotracheal Tube Fixation in Neonatal Preterm Infants: A Randomized Controlled Trial
It is aimed to minimise both unplanned extubation and skin damage with the surgical incision drep that we will use to fix the endotracheal tube in neonatal preterm infants and to reduce the complications that may develop due to these events.
In addition, it is aimed to evaluate the relationship between these parameters by using devices measuring skin moisture, skin pH and Neonatal Skin Condition Assessment Scale in experimental and control groups.
Study Overview
Detailed Description
The aim of this study is to investigate the effectiveness of surgical incision drape usage for securing endotracheal tubes in preterm neonates.
The study will be conducted using a randomized controlled design, and participants will be divided into two groups: those using the surgical drape and those not using it.
The population of the study will consist of preterm infants who are hospitalised in the neonatal intensive care unit of Batman Training and Research Hospital.
Intubated preterm infants between 28-34 weeks will be included in the study regardless of gender difference.
Research data will be collected by the following methods: Demographic information, Neonatal Skin Condition Rating Scale (NSCS), Skin Ph meter device and skin moisture meter device.
Data will be collected every 24 hours during the intubation period.
The results of the study are expected to provide important theoretical and practical contributions.
The effects of parameters such as skin wounds that may occur due to endotracheal tube fixation in infants, unplanned extubation rates, skin pH and skin moisture at the site of intubation fixation will be compared between the surgical incision drep and the standard group.
The research data will be analysed using IBM SPSS 27.0 Programme (Statistical Package for Social Sciences).
Study Type
Interventional
Enrollment (Estimated)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Barış Çelik
- Phone Number: 5424283452
- Email: c.celikbaris@gmail.com
Study Contact Backup
- Name: Ayla Yava
- Phone Number: 05372419171
- Email: ayla.yava@hku.edu.tr
Study Locations
-
-
-
Batman, Turkey, 72000
- Recruiting
- Barış Çelik
-
Contact:
- Barış Çelik
- Email: c.celikbaris@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Preterm infants between 28-34 weeks of gestation hospitalized in neonatal intensive care unit,
- Intubated infants on invasive mechanical ventilators,
- Babies who were orally intubated were included in the study.
Exclusion Criteria:
- Congenital skin condition,
- With circulatory problems,
- Congenital anomalies and metabolic disorders,
- Small for gestational age (SGA) and large for gestational age (LGA),
- Unplanned extubation taking place,
- Babies intubated for less than 24 hours will be excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Surgical Incision Drape
Participants in this group will have their endotracheal tube (ETT) secured using a surgical incision drape.
This method will be evaluated for its efficacy in preventing unplanned extubation and wound complications compared to the use of silk plasters.
|
To compare the efficacy of surgical incision with silk plaster in ETT fixation.
Other Names:
|
|
Active Comparator: silk plasters
The endotracheal tube (ETT) of the participants in this group will be secured using silk plasters.
This method will be evaluated for its efficacy in preventing unplanned extubation and wound complications compared to the use of a surgical incision drape.
|
To compare the efficacy of surgical incision with silk plaster in ETT fixation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
demographic data
Time Frame: through study completion, an average of 1 year
|
It will consist of questions such as gestational week, birth weight, postnatal age, frequency of endotracheal tube re-fixation, reason for hospitalization, frequency of aspiration, mode of delivery, gender, phototherapy status, antibiotic status, sedative use, analgesic use, ventilator mode.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
skin ph meter and skin moisture meter
Time Frame: through study completion, an average of 1 year
|
During the intubation period, skin pH and skin moisture meter data will be obtained from the experimental and control group patients every 24 hours at the intubation fixation site.
|
through study completion, an average of 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Newborn Skin Condition Assessment Scale
Time Frame: through study completion, an average of 1 year
|
Data will be collected every 24 hours.The scale consists of three dimensions including dryness, redness and impaired skin integrity/peeling.
The NSCS can be used in all newborns and a score between 3 and 9 is obtained.
The lowest score of 3 indicates the best skin score, while the highest score of 9 indicates the worst skin score.
skin wounds scores at the site of intubation tube fixation will be compared in experimental and control groups.
|
through study completion, an average of 1 year
|
|
unplanned extubation
Time Frame: through study completion, an average of 1 year
|
Data will be collected and statistical values will be calculated when an unplanned extubation event occurs in the experimental and control group patients while the patient is intubated.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Barış Çelik, Hasan Kalyoncu University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2024
Primary Completion (Estimated)
May 15, 2025
Study Completion (Estimated)
July 15, 2025
Study Registration Dates
First Submitted
December 7, 2024
First Submitted That Met QC Criteria
February 12, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 11, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/101
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.